×
App Icon
The Standard e-Paper
Stay Informed, Even Offline
★★★★ - on Play Store
Download App

Will Lenacapavir be the silver bullet in fight against HIV?

What you need to know about the new anti-HIV jab (Photo: Getty Images)

In 2016, Kenya was hailed as a global pioneer for rolling out daily Oral PrEP. Fast forward to 2026, and the data tells a more sobering story. According to the NSDCC 2025 Report, new HIV infections in Kenya surged by 19 per cent last year, reaching 20,000 cases.

Despite having initiated over 544,000 people on oral PrEP, we have hit a structural ceiling. The "daily pill" model is failing our most vulnerable.

Premium Article

Get Full Access for Ksh299/Week.

Bold Reporting Takes Time, Courage and Investment. Stand With Us.
Continue Reading  →
What you get
  • Unlimited access to all premium content
  • Ad-free browsing experience
  • Mobile-optimised reading
  • Weekly newsletters & digests
Pay via
M - PESA
VISA
Airtel Money
Secure Payments Kenya's most trusted newsroom since 1902